Note 12 - Subsequent Events	6 Months Ended
Jun. 30, 2026
Notes to Financial Statements
Subsequent Events [Text Block]	Note 12 — Subsequent Events Series E Preferred Stock Financing On July 9, 2026, the Company filed a Certificate of Designation of Rights and Preferences of the Series E Convertible Preferred Stock par value $0.0001 per share (“Series E Preferred Stock”) with the Secretary of State of the State of Nevada. The rights, preferences and limitations of the Series E Preferred Stock are set forth in the Certificate of Designation, including conversion rights into shares of the Company’s common stock, subject to certain limitations and adjustment provisions. On July 10, 2026, the Company and the Investor entered into a securities purchase agreement pursuant to which the Company issued the Investor 250 shares of the Company’s Series E Preferred Stock, for a purchase price of $1,000 per share. On July 31, 2026, the Company and the Investor entered into a securities purchase agreement pursuant to which the Company issued the Investor 150 shares of the Company’s Series E Preferred Stock for a purchase price of $1,000 per share. On August 18, 2026, the Company and the Investor entered into a securities purchase agreement pursuant to which the Company issued the Investor 210 shares of the Series E Preferred Stock, for a purchase price of $1,000 per share. Equity Issuances From August 3, 2026, through August 14, 2026, the holder of our Convertible Note 2026 converted $502,951 of principal and interest in exchange for a total of 698,775 common shares. On July 1, 2026, and July 21, 2026, the holder of the Series B preferred shares converted 12 of their preferred shares for a total of 82,272 common shares. From August 3, 2026, through August 10, 2026, the Company utilized its Equity Purchase Facility and sold 510,782 shares of common stock for proceeds from issuance of $336,242. On July 8, 2026, the Company accelerated all remaining Restricted Stock Units for a total of 535 shares. Nasdaq Notice Regarding Filing Deficiency On August 21, 2026, the Company received a notice from the Nasdaq Listing Qualifications Department (the “Staff”) that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2026 with the SEC. The Staff informed the Company that, under Nasdaq rules, the Company has 60 calendar days, or until October 20, 2026, to submit a plan to regain compliance, and if the Staff accepts such plan, it may grant an exception of up to 180 calendar days from the filing due date, or until February 16, 2027, to regain compliance.

Note 12 - Subsequent Events

6 Months Ended

Jun. 30, 2026

Note 12 — Subsequent Events

Series E Preferred Stock Financing

On July 9, 2026, the Company filed a Certificate of Designation of Rights and Preferences of the Series E Convertible Preferred Stock par value $0.0001 per share (“Series E Preferred Stock”) with the Secretary of State of the State of Nevada. The rights, preferences and limitations of the Series E Preferred Stock are set forth in the Certificate of Designation, including conversion rights into shares of the Company’s common stock, subject to certain limitations and adjustment provisions.

On July 10, 2026, the Company and the Investor entered into a securities purchase agreement pursuant to which the Company issued the Investor 250 shares of the Company’s Series E Preferred Stock, for a purchase price of $1,000 per share.

On July 31, 2026, the Company and the Investor entered into a securities purchase agreement pursuant to which the Company issued the Investor 150 shares of the Company’s Series E Preferred Stock for a purchase price of $1,000 per share.

On August 18, 2026, the Company and the Investor entered into a securities purchase agreement pursuant to which the Company issued the Investor 210 shares of the Series E Preferred Stock, for a purchase price of $1,000 per share.

Equity Issuances

From August 3, 2026, through August 14, 2026, the holder of our Convertible Note 2026 converted $502,951 of principal and interest in exchange for a total of 698,775 common shares.

On July 1, 2026, and July 21, 2026, the holder of the Series B preferred shares converted 12 of their preferred shares for a total of 82,272 common shares.

From August 3, 2026, through August 10, 2026, the Company utilized its Equity Purchase Facility and sold 510,782 shares of common stock for proceeds from issuance of $336,242.

On July 8, 2026, the Company accelerated all remaining Restricted Stock Units for a total of 535 shares.

Nasdaq Notice Regarding Filing Deficiency

On August 21, 2026, the Company received a notice from the Nasdaq Listing Qualifications Department (the “Staff”) that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2026 with the SEC. The Staff informed the Company that, under Nasdaq rules, the Company has 60 calendar days, or until October 20, 2026, to submit a plan to regain compliance, and if the Staff accepts such plan, it may grant an exception of up to 180 calendar days from the filing due date, or until February 16, 2027, to regain compliance.